Parisi R, Symmons DP, Griffiths CE, Ashcroft DM. Identification, Management of P, et al. Global epidemiology of psoriasis: a systematic review of incidence and prevalence. J Invest Dermatol. 2013;133(2):377–85.

CAS  Article  Google Scholar 

Kemeriz F, Tuğrul B, Tuncer S. C-reactive protein to albumin ratio: Is a new parameter for the disease severity in patients with psoriasis vulgaris? Dermatol Sin. 2020;38(4):199–204.

Article  Google Scholar 

Abuabara K, Azfar RS, Shin DB, Neimann AL, Troxel AB, Gelfand JM. Cause-specific mortality in patients with severe psoriasis: a population-based cohort study in the U.K. Br J Dermatol. 2010;163(3):586–92.

CAS  Article  Google Scholar 

Fang TP, Lin YC, Chi CC. Association of psoriasis with asthma: a systematic review and meta-analysis of observational studies. Dermatol Sin. 2020;38(1):22–7.

Article  Google Scholar 

Demirci O, Ates B, Sagaltici E, Ocak Z, Altunay I. Association of the attachment styles with depression, anxiety, and quality of life in patients with psoriasis. Dermatol Sin. 2020;38(2):81–7.

Article  Google Scholar 

Spah F. Inflammation in atherosclerosis and psoriasis: common pathogenic mechanisms and the potential for an integrated treatment approach. Br J Dermatol. 2008;159(Suppl 2):10–7.

Article  Google Scholar 

Ng CY, Huang YH, Tzeng IS, Liu SH, Chang YC. Changes in metabolic parameters in psoriasis patients treated with interleukin-12/23 blockade (ustekinumab). Dermatol Sin. 2020;38(3):166–71.

Article  Google Scholar 

Puig L. Cardiometabolic comorbidities in psoriasis and psoriatic arthritis. Int J Mol Sci. 2017;19(1):58.

Chen W, Chen W, Wang H, Dong X, Liu Q, Mao H, et al. Prevalence and risk factors associated with chronic kidney disease in an adult population from southern China. Nephrol Dial Transplant. 2009;24(4):1205–12.

Article  Google Scholar 

Cecchi R, Seghieri G, Gironi A, Tuci F, Giomi A. Relation between urinary albumin excretion and skin involvement in patients with psoriasis. Dermatology. 1992;185(2):93–5.

CAS  Article  Google Scholar 

Szepietowski JC, Bielicka E, Wasik F, Kopec W, Szepietowski T. Microalbuminuria as a subclinical marker of renal impairment in subjects with psoriasis vulgaris. J Eur Acad Dermatol Venereol. 2000;14(6):513–4.

CAS  Article  Google Scholar 

Dervisoglu E, Akturk AS, Yildiz K, Kiran R, Yilmaz A. The spectrum of renal abnormalities in patients with psoriasis. Int Urol Nephrol. 2012;44(2):509–14.

CAS  Article  Google Scholar 

Yang YW, Keller JJ, Lin HC. Medical comorbidity associated with psoriasis in adults: a population-based study. Br J Dermatol. 2011;165(5):1037–43.

Article  Google Scholar 

Wan J, Wang S, Haynes K, Denburg MR, Shin DB, Gelfand JM. Risk of moderate to advanced kidney disease in patients with psoriasis: population based cohort study. BMJ. 2013;347: f5961.

Article  Google Scholar 

Chi CC, Wang J, Chen YF, Wang SH, Chen FL, Tung TH. Risk of incident chronic kidney disease and end-stage renal disease in patients with psoriasis: a nationwide population-based cohort study. J Dermatol Sci. 2015;78(3):232–8.

Article  Google Scholar 

Yang SF, Chen TH, Tsai SH, Chen PE, Chi CC, Tung TH. Risk of chronic kidney disease and end-stage renal disease in patients with psoriasis: a systematic review and meta-analysis of cohort studies. Dermatol Sin. 2021;39(1):19–26.

Article  Google Scholar 

Krebs CF, Turner JE, Riedel JH, Panzer U. Tissue-specific therapy in immune-mediated kidney diseases: new ARGuments for targeting the IL-23/IL-17 axis. J Clin Invest. 2021;131(12):e150588.

Andrade-Oliveira V, Foresto-Neto O, Watanabe IKM, Zatz R, Camara NOS. Inflammation in renal diseases: new and old players. Front Pharmacol. 2019;10:1192.

CAS  Article  Google Scholar 

Mehaffey E, Majid DSA. Tumor necrosis factor-alpha, kidney function, and hypertension. Am J Physiol Renal Physiol. 2017;313(4):F1005–8.

Article  Google Scholar 

Li H, Tsokos MG, Bhargava R, Adamopoulos IE, Menn-Josephy H, Stillman IE, et al. IL-23 reshapes kidney resident cell metabolism and promotes local kidney inflammation. J Clin Invest. 2021;131(12):e142428.

Schmidt T, Luebbe J, Kilian C, Riedel JH, Hiekmann S, Asada N, et al. IL-17 receptor C signaling controls CD4(+) TH17 immune responses and tissue injury in immune-mediated kidney diseases. J Am Soc Nephrol. 2021;32(12):3081–98.

CAS  Article  Google Scholar 

Maghfour J, Elliott E, Gill F, Stumpf B, Murina A. Effect of biologic drugs on renal function in psoriasis patients with chronic kidney disease. J Am Acad Dermatol. 2020;82(5):1249–51.

CAS  Article  Google Scholar 

Tsai MS, Lin MH, Lee CP, Yang YH, Chen WC, Chang GH, et al. Chang Gung Research Database: A multi-institutional database consisting of original medical records. Biomed J. 2017;40(5):263–9.

Article  Google Scholar 

Shao SC, Chan YY, Kao Yang YH, Lin SJ, Hung MJ, Chien RN, et al. The Chang Gung Research Database-A multi-institutional electronic medical records database for real-world epidemiological studies in Taiwan. Pharmacoepidemiol Drug Saf. 2019;28(5):593–600.

Article  Google Scholar 

Wang SH, Chi CC, Hu S. Cost-efficacy of biologic therapies for moderate to severe psoriasis from the perspective of the Taiwanese healthcare system. Int J Dermatol. 2014;53(9):1151–6.

Article  Google Scholar 

Tsai TF, Lee CH, Huang YH, Chi CC, Chang YT, Wong TW, et al. Taiwanese Dermatological Association consensus statement on management of psoriasis. Dermatol Sin. 2017;35(2):66–77.

Article  Google Scholar 

Levey AS, Coresh J, Greene T, Stevens LA, Zhang YL, Hendriksen S, et al. Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate. Ann Intern Med. 2006;145(4):247–54.

CAS  Article  Google Scholar 

Uhlig K, Macleod A, Craig J, Lau J, Levey AS, Levin A, et al. Grading evidence and recommendations for clinical practice guidelines in nephrology. A position statement from Kidney Disease: improving Global Outcomes (KDIGO). Kidney Int. 2006;70(12):2058–65.

CAS  Article  Google Scholar 

Gisondi P, Girolomoni G. Glomerular filtration rate in patients with psoriasis treated with etanercept. J Int Med Res. 2016;44(1 suppl):106–8.

CAS  Article  Google Scholar 

Gisondi P, Pezzolo E, Girolomoni G. Glomerular filtration rate in patients with moderate-to-severe psoriasis. J Eur Acad Dermatol Venereol. 2019;33(6):e244–6.

CAS  Article  Google Scholar 

Hueber AJ, Tunc A, Schett G, Manger B. Anti-tumour necrosis factor alpha therapy in patients with impaired renal function. Ann Rheum Dis. 2007;66(7):981–2.

Article  Google Scholar 

Nimmannitya K, Tateishi C, Mizukami Y, Hamamoto K, Yamada S, Goto H, et al. Successful treatment with ustekinumab of psoriasis vulgaris in a patient undergoing hemodialysis. J Dermatol. 2016;43(1):92–4.

Article  Google Scholar 

Mikhaylov D, Hashim PW, Nektalova T, Goldenberg G. Systemic psoriasis therapies and comorbid disease in patients with psoriasis: a review of potential risks and benefits. J Clin Aesthet Dermatol. 2019;12(6):46–54.

PubMed  PubMed Central  Google Scholar 

Ikonomidis I, Papadavid E, Makavos G, Andreadou I, Varoudi M, Gravanis K, et al. Lowering interleukin-12 activity improves myocardial and vascular function compared with tumor necrosis factor-a antagonism or cyclosporine in psoriasis. Circ Cardiovasc Imaging. 2017;10(9):e006283.

Makavos G, Ikonomidis I, Andreadou I, Varoudi M, Kapniari I, Loukeri E, et al. Effects of interleukin 17a inhibition on myocardial deformation and vascular function in psoriasis. Can J Cardiol. 2020;36(1):100–11.

Article  Google Scholar 

Cortvrindt C, Speeckaert R, Moerman A, Delanghe JR, Speeckaert MM. The role of interleukin-17A in the pathogenesis of kidney diseases. Pathology. 2017;49(3):247–58.

CAS  Article  Google Scholar 

Lavoz C, Matus YS, Orejudo M, Carpio JD, Droguett A, Egido J, et al. Interleukin-17A blockade reduces albuminuria and kidney injury in an accelerated model of diabetic nephropathy. Kidney Int. 2019;95(6):1418–32.

CAS  Article  Google Scholar 

Amoruso GF, Nistico SP, Iannone L, Russo E, Rago G, Patruno C, et al. Ixekizumab may improve renal function in psoriasis. Healthcare (Basel). 2021;9(5):543.

Article  Google Scholar 

Ribero S, Conti V, Gambardella A, Der AB, Dapavo P, Argenziano G. Brodalumab treatment in psoriasis patients with severe renal failure. Ital J Dermatol Venerol. 2021;156(3):406–8.

PubMed  Google Scholar 

Mastorino L, Roccuzzo G, Dapavo P, Siliquini N, Avallone G, Rubatto M, et al. Patients with psoriasis resistant to multiple biological therapies: characteristics and definition of a difficult-to-treat population. Br J Dermatol. 2022;187(2):263–5.